Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 12 Jun 2021 |
2 | Reply to Exam Report (MIS-R) | 06 Jul 2021 |
3 | Journal Copy | 22 Jul 2022 |
4 | TM-O(NOTICE OF OPPOSITION) | 23 Sep 2022 |
5 | Annexure -1 under rule 46 | 27 Dec 2023 |
5 | Evidence Affidavit Under Rule 46 (TOP) | 27 Dec 2023 |
6 | Annexure -1 under rule 46 | 27 Dec 2023 |
6 | Evidence Affidavit Under Rule 46 (TOP) | 27 Dec 2023 |
1 | EXAMINATION REPORT | 11747269 | 01 Jul 2021 | |
2 | Hearing Notice (Show Cause) | 13259824 | 29 Mar 2022 | |
3 | Tribunal Accepted Notice for : 5002512 | 13480918 | 5603757 | 11 May 2022 |
4 | Opposition Notice | 14136411 | 5727695 | 26 Sep 2022 |
5 | Opposition Counter Statement | 15906333 | 6149840 | 26 Aug 2023 |
Revlad-dsr was applied on 12 June 2021.
Trademark application was filed by RELIABO PHARMA INDIA.
Trademark application has been filed under following classes.
5
As per IP India, trademark application is on the following stage:
Opposed.
Listed application Id of Revlad-dsr is 5002512.
Trademark attorney of the Revlad-dsr is D. Sen & Co.
Revlad-dsr is a DEVICE as per IP India data.